Aug 2026· Translational Oncology· Vol 72· 0 citations· 37 references
Medicine
TL;DR
A multimodal signature integrated CT radiomics, deep learning, and pathomics combined to predict progression-free survival in independent cohorts and may support postoperative risk stratification.
Abstract
Highlights • Prognostic tools remain limited for central conventional chondrosarcoma.• A multimodal signature integrated CT radiomics, deep learning, and pathomics.• The signature predicted progression-free survival in independent cohorts.• The signature may support postoperative risk stratification.
The authors are commend the authors for addressing the clinically important question of preoperative imaging biomarkers for survival prediction in glioblastoma (GBM), however, several methodological, data integrity concerns are raised.
Rohini Chaudhari, Varidh Katiyar, Sourabh Zambre· Indian Journal of Radiology...· 0 citations
A novel TIIC signature score predicts esophageal adenocarcinoma prognosis with high accuracy and offers insights into immune response and immunotherapy potential for EAC patients.
Shao Gao, Bing-Yan Du, Yeju He et al.· Translational Oncology· 0 citations
We aimed to develop models for predicting programmed death‐ligand 1 (PD‐L1) expression following neoadjuvant chemoradiotherapy (nCRT) in esophageal squamous cell carcinoma (ESCC) using a multifaceted approach that integrates traditional radiomics, deep learning, and machine learning.
Hyun Do Jung, Tae Hoon Lee, Byoung Hyuck Kim et al.· Cancer Medicine· 0 citations
Current FDA-approved treatments for CCA include therapies targeting HER2, IDH1, FGFR2, and other key biomarkers, including therapies targeting HER2, IDH1, FGFR2, and other key biomarkers.
Augusto Almeida, Joao Manzi, Camila Hoff et al.· Translational Oncology· 1 citation
Magnetic resonance imaging radiomics shows promise in guiding the selection of patients most likely to benefit from the use of immune checkpoint inhibitor therapy in patients with very‐high‐risk, nonmuscle‐invasive bladder cancer. This work arrives at a moment of rapid expansion in bladder‐sparing therapeutics, even as...
Colton H Walker, Navid Jabalameli, S. Rais-Bahrami· Cancer· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.